Non-caloric sweeteners and methods for synthesizing

US9850270B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9850270-B2
Application numberUS-201514873470-A
CountryUS
Kind codeB2
Filing dateOct 2, 2015
Priority dateOct 3, 2014
Publication dateDec 26, 2017
Grant dateDec 26, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are steviol glycosides referred to as rebaudioside V and rebaudioside W. Also disclosed are methods for producing rebaudioside M (Reb M), rebausoside G (Reb G), rebaudioside KA (Reb KA), rebaudioside V (Reb V) and rebaudioside (Reb W).

First claim

Opening claim text (preview).

What is claimed is: 1. A method for synthesizing a mixture of stevioside and rebaudioside KA from rubusoside, the method comprising: preparing an in vitro reaction mixture comprising rubusoside, uridine diphosphate (UDP), uridine diphosphate-glucose (UDP-glucose), and EUGT11 having the sequence of SEQ ID NO: 3, and thereafter, incubating the reaction mixture for a sufficient time to produce a mixture of stevioside and rebaudioside KA, wherein a glucose is covalently coupled to C2′-19-O-glucose of rubusoside to produce rebaudioside KA, and a glucose is covalently coupled to C2′-13-O-glucose of rubusoside to produce stevioside, and wherein the rebaudioside KA has the structure: 2. The method of claim 1 further comprising adding a sucrose synthase to the reaction mixture. 3. The method of claim 2 , wherein the sucrose synthase is selected from the group consisting of an Arabidopsis sucrose synthase 1; an Arabidopsis sucrose synthase 3; and a Vigna radiate sucrose synthase. 4. The method of claim 3 , wherein the sucrose synthase is an Arabidopsis thaliana sucrose synthase 1. 5. The method of claim 2 , wherein the reaction mixture further comprises sucrose. 6. The method of claim 5 , wherein the reaction mixture further comprises a UDP-glycosyltransferase fusion enzyme having the sequence of SEQ ID NO: 11. 7. The method of claim 1 , wherein the reaction mixture further comprises sucrose and a UDP-glycosyltransferase fusion enzyme having the sequence of SEQ ID NO: 11.

Assignees

Inventors

Classifications

  • Sucrose synthase (2.4.1.13) · CPC title

  • Polyterpene radicals · CPC title

  • Glucuronosyltransferase (2.4.1.17) · CPC title

  • Processes for the preparation of sugar derivatives · CPC title

  • C07H15/24Primary

    Condensed ring systems having three or more rings · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9850270B2 cover?
Disclosed are steviol glycosides referred to as rebaudioside V and rebaudioside W. Also disclosed are methods for producing rebaudioside M (Reb M), rebausoside G (Reb G), rebaudioside KA (Reb KA), rebaudioside V (Reb V) and rebaudioside (Reb W).
Who is the assignee on this patent?
Conagen Inc
What technology area does this patent fall under?
Primary CPC classification C07H15/24. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).